SMTL ID : 3r7y.1

CDK2 in complex with inhibitor KVR-2-88

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 3 residues within 4Å: Chain A: E.265, R.268, S.269 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.268 Water bridges: A:E.265, A:R.268, A:S.269

1 x Z04: 2-{[(2-aminopyrimidin-5-yl)methyl]amino}-4-(morpholin-4-yl)-5-nitrobenzamide(Non-covalent)

Z04.2: 14 residues within 4Å: Chain A: E.16, I.18, G.19, V.26, A.39, E.89, F.90, L.91, H.92, Q.93, D.94, K.97, Q.139, L.142 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:I.18, A:L.142 Hydrogen bonds: A:E.89, A:L.91, A:L.91, A:K.97 Water bridges: A:E.16, A:E.16 Salt bridges: A:E.16

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schonbrunn, E. et al., Structure-guided optimization of novel CDK2 inhibitors discovered by high-throughput screening. To be Published

Release Date

2012-08-08

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2

Related Entries With Identical Sequence